Digicann Ventures Inc (AGFAF)
0.0142
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
Digicann Ventures Enterprise Value: 0.5062M for June 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 0.5062M |
| June 13, 2024 | 0.5062M |
| June 12, 2024 | 0.5311M |
| June 11, 2024 | 0.5311M |
| June 10, 2024 | 0.4381M |
| June 07, 2024 | 0.7171M |
| June 06, 2024 | 0.7171M |
| June 05, 2024 | 0.6349M |
| June 04, 2024 | 0.5938M |
| June 03, 2024 | 0.5882M |
| May 31, 2024 | 0.5882M |
| May 30, 2024 | 0.5882M |
| May 29, 2024 | 0.5882M |
| May 28, 2024 | 0.5882M |
| May 24, 2024 | 0.5882M |
| May 23, 2024 | 0.5882M |
| May 22, 2024 | 0.5882M |
| May 21, 2024 | 0.5882M |
| May 20, 2024 | 0.5882M |
| May 17, 2024 | 0.5882M |
| May 16, 2024 | 0.4813M |
| May 15, 2024 | 0.4813M |
| May 14, 2024 | 0.4813M |
| May 13, 2024 | 0.4813M |
| May 10, 2024 | 0.4813M |
| Date | Value |
|---|---|
| May 09, 2024 | 0.4813M |
| May 08, 2024 | 0.4813M |
| May 07, 2024 | 0.4813M |
| May 06, 2024 | 0.5246M |
| May 03, 2024 | 0.4381M |
| May 02, 2024 | 0.5246M |
| May 01, 2024 | 0.5246M |
| April 30, 2024 | 0.4402M |
| April 29, 2024 | 0.4402M |
| April 26, 2024 | 0.4402M |
| April 25, 2024 | 0.4402M |
| April 24, 2024 | 0.4402M |
| April 23, 2024 | 0.4164M |
| April 22, 2024 | 0.4164M |
| April 19, 2024 | 0.4164M |
| April 18, 2024 | 0.5246M |
| April 17, 2024 | 0.5246M |
| April 16, 2024 | 0.468M |
| April 15, 2024 | 0.468M |
| April 12, 2024 | 0.5572M |
| April 11, 2024 | 0.5572M |
| April 10, 2024 | 0.468M |
| April 09, 2024 | 0.5287M |
| April 08, 2024 | 0.5287M |
| April 05, 2024 | 0.5287M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.3901M
Minimum
Jan 02 2024
194.68M
Maximum
Oct 18 2019
43.09M
Average
20.75M
Median
Jan 12 2022
Enterprise Value Benchmarks
| Acasti Pharma Inc | 5.205M |
| Aurinia Pharmaceuticals Inc | 457.57M |
| Edesa Biotech Inc | 11.51M |
| Lexaria Bioscience Corp | 34.65M |
| Xenon Pharmaceuticals Inc | 2.112B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.0153M |
| Total Expenses (Quarterly) | 0.0937M |
| EPS Diluted (Quarterly) | -0.0009 |
| Earnings Yield | 7.70K% |
| Normalized Earnings Yield | 1078.77 |